On March 1, 2019 Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) reported that it will report financial results for the fourth quarter and full year ended December 31, 2018, after the market close on Friday, March 8, 2019 (Press release, Conatus Pharmaceuticals, MAR 1, 2019, View Source [SID1234533874]). Conatus will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Friday, March 8, 2019, to discuss the financial results and provide a corporate update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the conference call, please dial 877-312-5857 (domestic) or 970-315-0455 (international) at least five minutes prior to the start time and refer to conference ID 3249458. A live and archived audio webcast of the call will also be available in the Investors section of the Conatus website at www.conatuspharma.com.